Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer
Array BioPharma Appoints Dr. Neil Spector to Its Scientific Advisory Board
May 1st, 2007
Array BioPharma Inc. (NASDAQ: ARRY) announced the appointment of Neil Spector, M.D., to its Scientific Advisory Board. Dr. Spector will focus on helping Array in the development of its cancer portfolio. "Dr. Spector's experience, bringing two targeted anti-cancer therapies from the bench all the way to market, will be a valuable asset for Array," said Kevin Koch, Ph.D., President and Chief Scientific Officer, Array BioPharma. "As the former Director of GlaxoSmithKline's Exploratory Medical Sciences in Oncology and the current Director of Translational Research in Oncology at Duke University Medical Center, he will contribute valuable knowledge and expertise as we move...
Source: Cancer Weekly (2007-05-01)
|
